U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. FDA Organization
  4. Center for Devices and Radiological Health
  5. Division of Patient-Centered Development
  6. CDRH Patient Engagement Advisory Committee
  1. Division of Patient-Centered Development

CDRH Patient Engagement Advisory Committee

Patient Engagement Advisory Committee: Advancing Health Equity in Medical Devices - Virtual Event September 6, 2023

2023 Advisory Committee Meeting

On September 6, 2023, in a virtual meeting, the Patient Engagement Advisory Committee (the Committee) will meet to discuss and make recommendations on Advancing Health Equity in Medical Devices.

FDA CDRH is committed to working toward assuring that all patients have access to high-quality, safe and effective medical devices. This includes ensuring devices are designed to be safe and effective when used by various populations, are evaluated in the diverse populations for which they are intended, and that patients and consumers have the information they need to make decisions about their health, care, and quality of life. In addition, technology, including digital health technology, may help bridge gaps in health equity by extending access and bringing health care to patients at home, at work, and in their communities. The recommendations provided by the committee will address considerations for the FDA and industry on these topics.

The Committee will consider ways to advance access to devices that allow for care outside a hospital or clinical care setting, for example, in the home setting.  The Committee will also discuss considerations for improving reach and comprehension of FDA’s patient and caregiver communications, across diverse demographic groups.  Additionally, the Committee will discuss patient-focused considerations for when a device should be evaluated in diverse populations to support marketing authorization.

For details, see September 6, 2023: Patient Engagement Advisory Committee Meeting Announcement.

The Patient Engagement Advisory Committee (PEAC) is the first and only advisory committee whose members are all patients, caregivers, and representatives of patient organizations.

The FDA established the Committee to help assure that the needs and experiences of patients are included as part of the FDA’s deliberations on complex issues involving the regulation of medical devices and their use by patients.

This Committee brings patients, caregivers, patient organizations, and experts together for a broader discussion of important patient-related issues. Such discussions may help inform device innovation, development, evaluation, and access, and help the FDA meet its public health commitment to protect and promote public health.

For details on the Patient Engagement Advisory Committee’s charter and past meeting materials, see Advisory Committees – Patient Engagement Advisory Committee.

Committee Membership

The Committee is made up of a core of nine voting members plus one non-voting industry representative and one voting consumer representative. For specific meetings that need expertise beyond the core membership, the Committee can reach out to experts that participate on this and other advisory panels for the FDA and the National Institutes of Health.

For details on current committee members, see Roster of the Patient Engagement Advisory Committee.

For information about how to nominate yourself or another candidate to participate in the Committee, see Applying for Membership on FDA Advisory Committees.

Discussion Topics

The Committee may advise CDRH on topics such as:

  • Agency guidance and policies
  • Design of clinical studies
  • Real-world data
  • Science of patient input
  • Communication of device benefits and risks
  • Digital health technology

Executive Summaries from previous Committee meetings include:

Actions taken by the FDA in response to feedback from the Committee meetings include:

Related information: Meeting materials for the Patient Engagement Advisory Committee

Federal Register Notices


Back to Top